
|Articles|October 1, 2001
Retinoic acid metabolism inhibitor causes less irritation
Washington - A series of cutaneous pharmacology studies conductedwith a selective retinoic acid metabolism inhibitor suggest this novel compoundhas the potential for treating a variety of retinoid-responsive dermatologicdiseases but with the advantage of causing less irritation compared to retinoicacid, Gerard J. Gendimenico, Ph.D., said at the Society for InvestigativeDermatology meeting.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older
3
Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis
4
Introducing Dermatology Times NP/PA Connect
5











